{"content":"<li class=\"n-box-item date-title\" data-end=\"1503547199\" data-start=\"1503460800\" data-txt=\"Monday, December 23, 2019\">Wednesday, August 23, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3291403\" data-ts=\"1503525429\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291403-guessplus-12-after-q2-earnings-beat-above-consensus-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess +12% after Q2 earnings beat, above consensus guidance</a></h4><ul>     <li>Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a>)&nbsp;<font color='green'>+12.2%</font>&nbsp;AH after reporting better than expected <a href=\"https://seekingalpha.com/news/3291365-guess-beats-0_09-beats-revenue\" target=\"_blank\">Q2 earnings</a> and offering upside Q3 guidance, foreseeing 4%-6% revenue growth vs. the 3% analyst consensus estimate.</li>     <li>GES attributes the strong performance to revenue gains in Europe and Asia as well as cost reductions in the supply chain, and the company expects continued revenue growth even as it closes stores in North America, where \"the business environment remains soft.\"</li><li>For Q3, GES guides EPS of $0.08-$0.11 vs. $0.12 analyst consensus, on 4%-6% revenue growth vs. 3% consensus; for the full-year, GES forecasts EPS of $0.52-$0.60 vs. $0.40 consensus, on 6%-7.5% revenue growth vs. 4.7% consensus.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291403\" data-linked=\"Guess +12% after Q2 earnings beat, above consensus guidance\" data-tweet=\"$GES - Guess +12% after Q2 earnings beat, above consensus guidance https://seekingalpha.com/news/3291403-guessplus-12-after-q2-earnings-beat-above-consensus-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3291403-guessplus-12-after-q2-earnings-beat-above-consensus-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291400\" data-ts=\"1503524350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291400-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/CO' title='Global Cord Blood Corporation'>CO</a> <font color='green'>+16.0%</font>. <a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+12.5%</font>. <a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='green'>+7.1%</font>. <a href='https://seekingalpha.com/symbol/WSM' title='Williams-Sonoma Inc.'>WSM</a> <font color='green'>+6.8%</font>. <a href='https://seekingalpha.com/symbol/PVH' title='PVH Corp.'>PVH</a> <font color='green'>+5.0%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/IEI' title='iShares 3-7 Year Treasury Bond ETF'>IEI</a> <font color='red'>-13.3%</font>. <a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='red'>-3.0%</font>. <a href='https://seekingalpha.com/symbol/FIVN' title='Five9, Inc.'>FIVN</a> <font color='red'>-1.6%</font>. <a href='https://seekingalpha.com/symbol/MBT' title='Mobile TeleSystems'>MBT</a> <font color='red'>-1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291400\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CO $GES $TLYS - After Hours Gainers / Losers https://seekingalpha.com/news/3291400-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3291400-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291389\" data-ts=\"1503521757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLNKF\" target=\"_blank\">BLNKF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291389-yume-up-again-confirms-talks-rhythmone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YuMe up again as it confirms talks with RhythmOne</a></h4><ul>   <li>YuMe (<a href=\"http://seekingalpha.com/symbol/YUME\" target=\"_blank\">YUME</a> <font color='green'>+1.8%</font>) -- which launched a <a href=\"https://seekingalpha.com/news/3223124-yume-cleans-house-names-interim-ceo-sets-restructuring\" target=\"_blank\">review of strategic alternatives</a> last fall -- is <font color='green'>up 1%</font> after hours after confirming an earlier report that it's been talking with RhythmOne (<a href='https://seekingalpha.com/symbol/BLNKF' title='RHYTHMONE PLC ORD NEW'>OTCPK:BLNKF</a>).</li>    <li>RhythmOne, an online advertising company, said it was in talks to potentially buy YuMe, which offers digital video brand advertising.</li>    <li>YuMe confirmed that \"it is in discussions regarding a potential transaction with RhythmOne\" but continues to review all alternatives, including remaining as a stand-alone firm.</li><li>YuMe has a market cap of just under $178M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291389\" data-linked=\"YuMe up again as it confirms talks with RhythmOne\" data-tweet=\"$BLNKF $BLNKF $YUME - YuMe up again as it confirms talks with RhythmOne https://seekingalpha.com/news/3291389-yume-up-again-confirms-talks-rhythmone?source=tweet\" data-url=\"https://seekingalpha.com/news/3291389-yume-up-again-confirms-talks-rhythmone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291386\" data-ts=\"1503521142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291386-hp-reports-q3-results-beats-positive-guidance-printing-down-on-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP reports Q3 results with beats, positive guidance, Printing down on quarter</a></h4><ul><li>        HP (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>) trades&nbsp;<font color='red'>down 1.11%</font>&nbsp;aftermarket following &nbsp;Q3 earnings with EPS and revenue beats with sales up nearly 10% on the year. Q4 guidance puts EPS from $0.42 to $0.45, slightly above the $0.44 consensus, while FY17 has the range from $1.63 to $1.66, above the $1.64 consensus.</li><li>                  Segment revenue and margins: Personal Systems, $8.4B (+12% Y/Y) with 3.7% margin (-70 basis points) and Printing, $4.7B (+6%) with 17.3% margin (-310 bps).   </li><li>               In Personal Systems, Notebook sales were up 16% in revenue to $5B and 12% in units. Desktops were up 5% in revenue to $2.6B and 3% in units.&nbsp;</li><li>               In Printing, Supplies was up 10% on the year to $3.12B but down 1% on the quarter. Commercial Hardware fell 2% to $986M while Consumer Hardware grew 3% to $592M.&nbsp;</li><li>               Key financials: R&amp;D costs were $289M (-3%) and SG&amp;A reported at about $1.1B (+52%). Cash from operating activities was $1.8B. HP returned $524M to shareholders in the quarter. The company ended the quarter with nearly $7B in cash and equivalents.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/16922625-hp-inc-reports-fiscal-2017-third-quarter-results\" target=\"_blank\">Press release</a>&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291355-hp-beats-0_01-beats-revenue\" target=\"_blank\">HP beats by $0.01, beats on revenue</a> (Aug. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291386\" data-linked=\"HP reports Q3 results with beats, positive guidance, Printing down on quarter\" data-tweet=\"$HPQ - HP reports Q3 results with beats, positive guidance, Printing down on quarter https://seekingalpha.com/news/3291386-hp-reports-q3-results-beats-positive-guidance-printing-down-on-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3291386-hp-reports-q3-results-beats-positive-guidance-printing-down-on-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291382\" data-ts=\"1503520664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291382-new-jersey-oks-centurylinks-level-3-buyout-california-is-last\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Jersey OKs CenturyLink&#39;s Level 3 buyout; California is last</a></h4><ul>   <li>New Jersey has <a href=\"https://seekingalpha.com/pr/16922640-another-state-approves-centurylink-acquisition-level-3\" target=\"_blank\">cleared the way</a> for CenturyLink's (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color='green'>+2.4%</font>) $34B acquisition of Level 3 Communications (<a href=\"http://seekingalpha.com/symbol/LVLT\" target=\"_blank\">LVLT</a> <font color='green'>+1.2%</font>), joining 23 other states and districts in signing off on the deal.</li>    <li>In terms of state jurisdictions, that leaves only California as the location yet to approve or clear the deal.</li>    <li>Some basic regulatory approvals and customary closing conditions are left. The company says it's working with California's Public Utilities Commission to ensure the deal closes on target by the end of Q3.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291382\" data-linked=\"New Jersey OKs CenturyLink&#39;s Level 3 buyout; California is last\" data-tweet=\"$CTL $CTL $LVLT - New Jersey OKs CenturyLink&#39;s Level 3 buyout; California is last https://seekingalpha.com/news/3291382-new-jersey-oks-centurylinks-level-3-buyout-california-is-last?source=tweet\" data-url=\"https://seekingalpha.com/news/3291382-new-jersey-oks-centurylinks-level-3-buyout-california-is-last\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291373\" data-ts=\"1503519839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291373-tillys-flies-after-sales-gain-traction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilly&#39;s flies after sales gain traction</a></h4><ul> <li>Tilly's (NYSE:<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a>) reports comparable sales rose 2.1% in Q2.</li> <li>\"We believe the combination of our merchandising, marketing and operating initiatives is gaining traction, as evidenced by our positive comps and improved store traffic,\" notes CEO Ed Thomas.</li> <li>Gross profit as a percentage of sales rose 50 bps to 29.5% during the quarter as a lower level of markdowns played in.</li> <li>Looking ahead, Tilly's expects Q3 EPS of $0.19 to $0.24 vs. $0.17 consensus off of comparable sales growth in a range of flat to up at a low single digit rate.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291357-tillys-beats-0_06-beats-revenue\" target=\"_blank\">Tilly's beats by $0.06, beats on revenue</a> (Aug. 23)</li> <li>TLYS <font color='green'>+8.65</font>% AH to $10.43.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291373\" data-linked=\"Tilly&#39;s flies after sales gain traction\" data-tweet=\"$TLYS - Tilly&#39;s flies after sales gain traction https://seekingalpha.com/news/3291373-tillys-flies-after-sales-gain-traction?source=tweet\" data-url=\"https://seekingalpha.com/news/3291373-tillys-flies-after-sales-gain-traction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291365\" data-ts=\"1503519420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291365-guess-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess beats by $0.09, beats on revenue</a></h4><ul><li>Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a>): Q2 EPS of $0.19 <font color='green'>beats by $0.09</font>.</li><li>Revenue of $573.7M (+5.3% Y/Y) <font color='green'>beats by $14.65M</font>.</li><li>Shares <font color='green'>+3.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16922654-guess-inc-reports-second-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3291365\" data-linked=\"Guess beats by $0.09, beats on revenue\" data-tweet=\"$GES - Guess beats by $0.09, beats on revenue https://seekingalpha.com/news/3291365-guess-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3291365-guess-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291363\" data-ts=\"1503519224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NPTN\" target=\"_blank\">NPTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291363-optical-component-makers-spike-on-report-of-china-mobile-tender\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Optical component makers spike on report of China Mobile tender</a></h4><ul>   <li>A tender for optical components by China Mobile (<a href=\"http://seekingalpha.com/symbol/CHL\" target=\"_blank\">CHL</a> <font color='red'>-0.2%</font>) has forced an end-of-day spike for makers of those components.</li>    <li>NeoPhotonics (NYSE:<a href='https://seekingalpha.com/symbol/NPTN' title='NeoPhotonics Corporation'>NPTN</a>) <font color='green'>jumped 10.7%</font>; Oclaro (NASDAQ:<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) <font color='green'>rose 5.6%</font>; Acacia (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIA' title='Acacia Communications'>ACIA</a>) <font color='green'>jumped 5.5%</font>; and Applied Optoelectronics (NASDAQ:<a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>) <font color='green'>rose 4.1%</font> after a report by Rosenblatt's Jun Zhang pointed to the tender, part of a project to build 50,000-70,000 40G/100G ports, according to the note.</li>    <li>Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>) <font color='green'>jumped 3.3%</font> and Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) <font color='green'>rose 3%</font>.</li>    <li>Huawei is likely to take 50% of the order, Zhang says -- and it makes up 18% of Oclaro's total revenue as well as 17% of Lumentum's and 11% of Finisar's, Bloomberg says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291363\" data-linked=\"Optical component makers spike on report of China Mobile tender\" data-tweet=\"$NPTN $NPTN $OCLR - Optical component makers spike on report of China Mobile tender https://seekingalpha.com/news/3291363-optical-component-makers-spike-on-report-of-china-mobile-tender?source=tweet\" data-url=\"https://seekingalpha.com/news/3291363-optical-component-makers-spike-on-report-of-china-mobile-tender\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291357\" data-ts=\"1503518898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLYS\" target=\"_blank\">TLYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291357-tillys-beats-0_06-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilly&#39;s beats by $0.06, beats on revenue</a></h4><ul><li>Tilly's (NYSE:<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a>): Q2 EPS of $0.11 <font color='green'>beats by $0.06</font>.</li><li>Revenue of $138.8M (+1.8% Y/Y) <font color='green'>beats by $2.81M</font>.</li><li>Shares <font color='green'>+6.7%</font>.</li><li><a href='https://seekingalpha.com/pr/16922613-tilly-s-inc-announces-fiscal-2017-second-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3291357\" data-linked=\"Tilly&#39;s beats by $0.06, beats on revenue\" data-tweet=\"$TLYS - Tilly&#39;s beats by $0.06, beats on revenue https://seekingalpha.com/news/3291357-tillys-beats-0_06-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3291357-tillys-beats-0_06-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291355\" data-ts=\"1503518804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPQ\" target=\"_blank\">HPQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291355-hp-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP beats by $0.01, beats on revenue</a></h4><ul><li>HP (NYSE:<a href='https://seekingalpha.com/symbol/HPQ' title='HP Inc.'>HPQ</a>): Q3 EPS of $0.43 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $13.06B (+9.8% Y/Y) <font color='green'>beats by $750M</font>.</li><li>Shares <font color='green'>+2.5%</font>.</li><li><a href='https://seekingalpha.com/pr/16922625-hp-inc-reports-fiscal-2017-third-quarter-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3291355\" data-linked=\"HP beats by $0.01, beats on revenue\" data-tweet=\"$HPQ - HP beats by $0.01, beats on revenue https://seekingalpha.com/news/3291355-hp-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3291355-hp-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291348\" data-ts=\"1503518357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IAG\" target=\"_blank\">IAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291348-iamgold-upgraded-bmo-citing-saramacca-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IAMGOLD upgraded at BMO, citing Saramacca optimism</a></h4><ul>     <li>IAMGOLD (<a href='https://seekingalpha.com/symbol/IAG' title='IAMGOLD Corporation'>IAG</a> <font color='green'>+3.6%</font>) enjoys strong gains today after BMO&nbsp;Capital <a href=\"http://thefly.com/thestreet/realmoney/index.php/IAGid2600061/IAG-IAMGold-upgraded-to-Outperform-at-BMO-Capital\" target=\"_blank\">upgraded</a> shares to Outperform from Market Perform with a $7.50 price target, hiked from $6.</li>     <li>BMO believes IAG's Saramacca resources will be of a higher grade and potentially larger than the company's initial estimate, and notes the miner plans to complete a resource estimate at the Saramacca project in Q3.</li>     <li>IAG acquired the Saramacca property from the government of Suriname in August 2016 with the intent of defining a 43-101 compliant mineral resource within the next 24 months.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291348\" data-linked=\"IAMGOLD upgraded at BMO, citing Saramacca optimism\" data-tweet=\"$IAG - IAMGOLD upgraded at BMO, citing Saramacca optimism https://seekingalpha.com/news/3291348-iamgold-upgraded-bmo-citing-saramacca-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3291348-iamgold-upgraded-bmo-citing-saramacca-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291344\" data-ts=\"1503517444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMNP\" target=\"_blank\">IMNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291344-immune-pharma-pops-up-118\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Pharma pops, up 118%</a></h4><ul><li>Short sellers of Immune Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+117.5%</font>)&nbsp;are running for cover. Shares had lost almost 65% of their value since late June before today's high-volume action.</li><li>The company is advancing a spinoff of Cytovia which will focus on developing cancer drug CEPLENE (histamine dihydrochloride).</li><li>On August 14, it announced the hiring of a new COO and Chief Medical Officer to lead the development effort for bertilimumab, a monoclonal antibody for the potential treatment of bullous pemphigoid and ulcerative colitis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3289063-new-operating-chief-immune-pharma-slide-continues-shares-10-percent\" target=\"_blank\">New operating chief at Immune Pharma; slide continues, shares down 10%</a> (Aug. 14)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286008-immune-pharmas-strategic-plan-planned-cytovia-spinout-fail-stem-wave-selling-shares-21\" target=\"_blank\">Immune Pharma's strategic plan and planned Cytovia spinout fail to stem the wave of selling; shares down 21%</a> (Aug. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291344\" data-linked=\"Immune Pharma pops, up 118%\" data-tweet=\"$IMNP $IMNPQ - Immune Pharma pops, up 118% https://seekingalpha.com/news/3291344-immune-pharma-pops-up-118?source=tweet\" data-url=\"https://seekingalpha.com/news/3291344-immune-pharma-pops-up-118\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291343\" data-ts=\"1503517020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291343-ad-agencies-slide-wpp-earnings-portend-heavy-slowdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad agencies slide as WPP earnings portend heavy slowdown</a></h4><ul>   <li>With <a href=\"https://seekingalpha.com/news/3291313-wpp-minus-11_4-percent-results-show-sharp-ad-slowdown\" target=\"_blank\">rough earnings</a> from WPP (<a href=\"http://seekingalpha.com/symbol/WPPGY\" target=\"_blank\">WPPGY</a> <font color='red'>-11.5%</font>) serving as a global advertising bellwether, rivals' stocks have declined today, along with many from complementary media companies.</li>    <li>Interpublic Group (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>) has <font color='red'>slipped 6.1%</font> to a near-two-year low. Omnicom (NYSE:<a href='https://seekingalpha.com/symbol/OMC' title='Omnicom Group Inc.'>OMC</a>) is <font color='red'>off 6.7%</font> to a 52-week low. And Publicis Groupe (<a href='https://seekingalpha.com/symbol/PUBGY' title='Publicis Groupe S.A. ADR'>OTCQX:PUBGY</a>) is <font color='red'>2.7% lower</font>.</li>    <li>WPP is the world's largest advertising company, so its warnings about a potential sharp pullback in spending from advertisers (particularly in North America) are being heard by investors far and wide. Media stocks are generally lower as a sector.</li>    <li>In Europe, ITV declined (<a href='https://seekingalpha.com/symbol/ITVPY' title='ITV Plc. ADR'>OTCPK:ITVPY</a> is <font color='red'>2.4% lower</font> in OTC trading). Sky (<a href='https://seekingalpha.com/symbol/SKYAY' title='Sky Plc ADR'>OTCPK:SKYAY</a>) is <font color='red'>0.7% lower</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291343\" data-linked=\"Ad agencies slide as WPP earnings portend heavy slowdown\" data-tweet=\"$IPG $IPG $OMC - Ad agencies slide as WPP earnings portend heavy slowdown https://seekingalpha.com/news/3291343-ad-agencies-slide-wpp-earnings-portend-heavy-slowdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3291343-ad-agencies-slide-wpp-earnings-portend-heavy-slowdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291342\" data-ts=\"1503516907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEIS\" target=\"_blank\">AEIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291342-advanced-energy-initiated-hold-rating-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advanced Energy initiated with Hold rating at Stifel</a></h4><ul>     <li>Advanced Energy Industries (<a href='https://seekingalpha.com/symbol/AEIS' title='Advanced Energy Industries, Inc.'>AEIS</a> <font color='red'>-2.6%</font>) is started with a <a href=\"https://www.streetinsider.com/Analyst+Comments/Stifel+Starts+Advanced+Energy+Industries+%28AEIS%29+at+Hold/13228420.html\" target=\"_blank\">Hold rating</a> and a $74 price target at Stifel, which believes the company is well positioned fundamentally to outpace the overall WFE market but prefers a  better entry point for the stock.</li><li>Stifel sees three key investment highlights for AEIS: The company is well positioned to capitalize upon the increasing capital intensity trends in the etch and deposition markets; with its decision to divest  and close its low-margin solar inverter business, AEIS has seen a significant improvement in its operating model; and participation in the non-semis/industrial market provides an avenue for diversification and growth in its own right.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3291342\" data-linked=\"Advanced Energy initiated with Hold rating at Stifel\" data-tweet=\"$AEIS - Advanced Energy initiated with Hold rating at Stifel https://seekingalpha.com/news/3291342-advanced-energy-initiated-hold-rating-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3291342-advanced-energy-initiated-hold-rating-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291336\" data-ts=\"1503516255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETS\" target=\"_blank\">PETS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291336-petmed-express-takes-issue-false-and-defamatory-report-stock-rebounds-15-from-session-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetMed Express takes issue with &quot;false and defamatory&quot; report; stock rebounds 15% from session low</a></h4><ul><li>PetMed Express (<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-7.1%</font>) is down for the day on a 27x surge in volume, but the stock has bounced back over 15% from the intraday low of $31.92.</li><li>In a <a href=\"https://seekingalpha.com/pr/16922513-short-sellers-attack-petmed-express-d-b-1minus-800-petmeds-false-defamatory-report\" target=\"_blank\">statement</a>, it acknowledges that it sells opioid Tramadol and and anticonvulsant Gabapentin, but they account for less than 1% of annual revenue. It adds that it dispenses the medications for animals only under valid prescriptions and will defend itself \"vigorously against these false allegations.\"</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291312-petmed-express-continues-slide-14-percent\" target=\"_blank\">PetMed Express continues slide, down 14%</a> (Aug. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291336\" data-linked=\"PetMed Express takes issue with &quot;false and defamatory&quot; report; stock rebounds 15% from session low\" data-tweet=\"$PETS - PetMed Express takes issue with &quot;false and defamatory&quot; report; stock rebounds 15% from session low https://seekingalpha.com/news/3291336-petmed-express-takes-issue-false-and-defamatory-report-stock-rebounds-15-from-session-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3291336-petmed-express-takes-issue-false-and-defamatory-report-stock-rebounds-15-from-session-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291329\" data-ts=\"1503514548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291329-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/LOV' title='Spark Networks, Inc'>LOV</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CYBE' title='CyberOptics Corporation'>CYBE</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a> <font color='red'>-9%</font>. WPCS <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291329\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$SQNS $VERI $LOV - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3291329-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3291329-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291327\" data-ts=\"1503513972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDSN\" target=\"_blank\">NDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291327-nordson-upgraded-to-buy-gabelli-selloff-presents-buying-opportunity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordson upgraded to Buy at Gabelli, as selloff presents buying opportunity</a></h4><ul>     <li>Nordson (<a href='https://seekingalpha.com/symbol/NDSN' title='Nordson Corporation'>NDSN</a> <font color='red'>-1.9%</font>) is lower despite winning an <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Gabelli+Upgrades+Nordson+%28NDSN%29+to+Buy/13229930.html\" target=\"_blank\">upgrade to Buy</a> from Hold at Gabelli, which says the stock's post-earnings selloff presents a buying opportunity.</li>     <li>NDSN shares sold off by more than 10% after releasing <a href=\"https://seekingalpha.com/news/3290824-nordson-minus-11-percent-consensus-fq4-outlook\" target=\"_blank\">strong FQ3 results</a> with a soft FQ4 outlook, but Gabelli says the company shows no structural deterioration in fundamentals around growing end markets.</li>     <li>Gabelli considers NDSN a high-quality compounder with enduring competitive advantages in consumer-oriented end markets that offer better growth and profitability opportunities than those available to a typical industrial manufacturer, and is an excellent cash generator to boot.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291327\" data-linked=\"Nordson upgraded to Buy at Gabelli, as selloff presents buying opportunity\" data-tweet=\"$NDSN - Nordson upgraded to Buy at Gabelli, as selloff presents buying opportunity https://seekingalpha.com/news/3291327-nordson-upgraded-to-buy-gabelli-selloff-presents-buying-opportunity?source=tweet\" data-url=\"https://seekingalpha.com/news/3291327-nordson-upgraded-to-buy-gabelli-selloff-presents-buying-opportunity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291326\" data-ts=\"1503513943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVLV\" target=\"_blank\">EVLV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291326-evine-liveminus-9_9-amid-continued-revenue-decline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EVINE Live -9.9% amid continued revenue decline</a></h4><ul>   <li>EVINE Live (NASDAQ:<a href='https://seekingalpha.com/symbol/EVLV' title='EVINE Live Inc.'>EVLV</a>) has <font color='red'>fallen 9.9%</font> today, a couple of pennies above a 52-week low, after its <a href=\"https://seekingalpha.com/news/3291154-evine-live-eps-line-misses-revenue\" target=\"_blank\">Q2 revenues</a> missed though the company said its turnaround was at hand.</li>    <li>&ldquo;This second quarter is the final quarter of expected revenue decline, which was related to the year-long rebalancing of our Consumer Electronics mix of business that began in April of last year,\" says CEO Bob Rosenblatt.</li>    <li>Revenues fell 5.2% Y/Y and led to a net loss of $2M (flat).</li>    <li>Gross profit as percentage of sales fell 20 basis points, to 37.9%.</li>    <li>EBITDA of $3.5M was down 9% but beat an expected $3.08M.</li>    <li>Net merchandise sales mix: Jewelry and Watches, 40% (vs. year-ago 41%); Home and Consumer Electronics, 23% (vs. year-ago 21%); Beauty, 16% (same as prior); Fashion and Accessories, 21% (vs. year-ago 22%).</li>    <li>For Q3, it's expecting revenue growth in low single digits and \"slightly improved\" net income and EPS. For the full year, it's forecasting EBITDA of $18M-$22M (vs. consensus for $20M).</li>    <li><a href=\"https://seekingalpha.com/pr/16921719-evine-live-inc-reports-second-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3291326\" data-linked=\"EVINE Live -9.9% amid continued revenue decline\" data-tweet=\"$EVLV $IMBI - EVINE Live -9.9% amid continued revenue decline https://seekingalpha.com/news/3291326-evine-liveminus-9_9-amid-continued-revenue-decline?source=tweet\" data-url=\"https://seekingalpha.com/news/3291326-evine-liveminus-9_9-amid-continued-revenue-decline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291323\" data-ts=\"1503513139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291323-american-eagle-outfitters-rallies-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Eagle Outfitters rallies after earnings</a></h4><ul> <li>American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+6.6%</font>) rode the back of a 26% pop in comparable sales for the Aerie brand to a Q2 earnings beat. Despite a year-over-year drop in profit, analysts and investors are positive on the results.</li> <li>\"Cautious optimism as early signs suggest improving trends in 3Q,\" tweets Buckingham Research.</li> <li>\"We are particularly encouraged by the progress made in categories like jeans where more emphasis on features like style and fit have helped to boost sales and attract more customers,\" GlobalData Retail analyst Anthony Riva chimes in.</li> <li>Sources: CNBC and Buckingham Research's <a href=\"https://twitter.com/BuckResearch/status/900422920454975489\" target=\"_blank\">Twitter feed</a></li> <li>Shares of AEO popped their heads over the $12 level before dropping back again.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291209-american-eagle-outfitters-higher-earnings-beat\" target=\"_blank\">American Eagle Outfitters higher on earnings beat</a> (Aug. 23)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291323\" data-linked=\"American Eagle Outfitters rallies after earnings\" data-tweet=\"$AEO - American Eagle Outfitters rallies after earnings https://seekingalpha.com/news/3291323-american-eagle-outfitters-rallies-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3291323-american-eagle-outfitters-rallies-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291319\" data-ts=\"1503511234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291319-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/XCO' title='EXCO Resources, Inc.'>XCO</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NGVT' title='Ingevity Corporation'>NGVT</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/UNT' title='Unit Corporation'>UNT</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WMLP-OLD' title='Westmoreland Resource Partners, LP'>WMLP-OLD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MBII' title='Marrone Bio Innovations, Inc.'>MBII</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/WRN' title='Western Copper and Gold Corporation'>WRN</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291319\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$CGG-OLD $XCO $NGVT - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3291319-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3291319-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291316\" data-ts=\"1503510981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291316-omeros-continues-legal-fight-bearish-reporter-doyle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Omeros continues legal fight with bearish reporter Doyle</a></h4><ul><li>In a <a href=\"http://investor.omeros.com/phoenix.zhtml?c=219263&amp;p=irol-newsArticle_Print&amp;ID=2295254\" target=\"_blank\">press release</a> published today, Omeros (<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a> <font color='red'>-0.5%</font>) says it is continuing to pursue legal action against an unidentified online author writing under the pseudonym \"Art Doyle\" who published a bearish report in <a href=\"http://www.seattletimes.com/business/technology/seattle-biotech-omeros-threatens-legal-action-against-author-of-critical-report/\" target=\"_blank\">late June</a> proclaiming that the company's stock was headed to $1.</li><li>The company says the report from the admitted short seller is riddled with inaccuracies. A Seattle court apparently agrees, granting the company's motion for preliminary injunction requiring the removal of the defamatory reports and prohibiting further disparaging statements.</li><li>It adds that it would not ordinarily engage in a dialogue with the author, but will list specific details about its data disclosures related to lead candidate OMS721 that it says proves its point that Doyle's article lacks credibility.</li><li>Since late June, shares are basically flat, albeit with some volatility, so investors are not headed to the exits just yet.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291316\" data-linked=\"Omeros continues legal fight with bearish reporter Doyle\" data-tweet=\"$OMER - Omeros continues legal fight with bearish reporter Doyle https://seekingalpha.com/news/3291316-omeros-continues-legal-fight-bearish-reporter-doyle?source=tweet\" data-url=\"https://seekingalpha.com/news/3291316-omeros-continues-legal-fight-bearish-reporter-doyle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291315\" data-ts=\"1503510768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELVT\" target=\"_blank\">ELVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291315-btig-spots-buying-opportunity-in-elevate-credit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BTIG spots buying opportunity in Elevate Credit</a></h4><ul><li>Elevate Credit (<a href='https://seekingalpha.com/symbol/ELVT' title='Elevate Credit'>ELVT</a> <font color='red'>-7.3%</font>) is tumbling, perhaps <a href=\"https://seekingalpha.com/news/3290911-u-k-subprime-lender-implodes\" target=\"_blank\">in wake of the implosion </a>of U.K. subprime lender Provident Financial (though that happened yesterday).</li><li>Provident's troubles are the result of management missteps, says Palmer, and he's not seeing any read-through for Elevate. In fact, the whole affair should set Elevate up to grab market share.</li><li>Palmer reiterates his Buy rating and $12 price target, suggesting&nbsp;<font color='green'>100% upside&nbsp;</font>from the current price.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291315\" data-linked=\"BTIG spots buying opportunity in Elevate Credit\" data-tweet=\"$ELVT - BTIG spots buying opportunity in Elevate Credit https://seekingalpha.com/news/3291315-btig-spots-buying-opportunity-in-elevate-credit?source=tweet\" data-url=\"https://seekingalpha.com/news/3291315-btig-spots-buying-opportunity-in-elevate-credit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291313\" data-ts=\"1503510018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPP\" target=\"_blank\">WPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291313-wppminus-11_4-results-show-sharp-ad-slowdown\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPP -11.4% as results show sharp ad slowdown</a></h4><ul>   <li>WPP (WPPGY) has tumbled today, <font color='red'>down 11.4%</font> after <a href=\"https://seekingalpha.com/news/3291149-wpp-plc-reports-1h-results\" target=\"_blank\">reporting on a first half</a> that reinforced worries about slow or no growth in ad spending, especially in North America.</li>    <li>In a long discussion session, CEO Martin Sorrell warned of nearly two dozen factors holding back ad growth worldwide, including the dominance of Google and Facebook, and changes to a retail environment disrupted by Amazon.com.</li>    <li>Profit per share came in as expected at 46.6 pence, but revenues of &pound;7.4B missed consensus for &pound;7.48B.</li>    <li>Billings rose 6.3% to &pound;26.9B, but fell 4.7% in constant currency. While as-reported revenue was up 13.3%, like-for-like was down 0.3% (2.2% growth from acquisitions, and 11.4% from currency amid weak sterling) -- that vs. four years of like-for-like growth of 3%-plus.</li>    <li>The company did show constant-currency revenue growth in all regions and sectors except data investment management.</li>    <li><a href=\"http://www.wpp.com/wpp/investor/financialnews/2017/aug/23/wpp-interim-results-2017/\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3291313\" data-linked=\"WPP -11.4% as results show sharp ad slowdown\" data-tweet=\"$WPP - WPP -11.4% as results show sharp ad slowdown https://seekingalpha.com/news/3291313-wppminus-11_4-results-show-sharp-ad-slowdown?source=tweet\" data-url=\"https://seekingalpha.com/news/3291313-wppminus-11_4-results-show-sharp-ad-slowdown\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291312\" data-ts=\"1503509290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETS\" target=\"_blank\">PETS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291312-petmed-express-continues-slide-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetMed Express continues slide, down 14%</a></h4><ul><li>The selling has intensified in PetMed Express (<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-13.7%</font>) on an 11x surge in volume. Shares have lost a third of their value since touching $50.90 on July 27.</li><li>Two articles were published today that are, no doubt, contributing to the selloff. The first, from <a href=\"http://aureliusvalue.com/research/petmed-exploiting-americas-opioid-epidemic/\" target=\"_blank\">Aurelius Value</a>, claims the company's bullish results the past two quarters are due to its promotion of opioids to humans, not pets. The second, by Huffington Post, addresses the growing problem of pet owners <a href=\"http://www.huffingtonpost.com/entry/war-on-opioids-moves-to-veterinarians-offices_us_599d936de4b02289f7619172\" target=\"_blank\">procuring opioids</a> from veterinarians.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291312\" data-linked=\"PetMed Express continues slide, down 14%\" data-tweet=\"$PETS - PetMed Express continues slide, down 14% https://seekingalpha.com/news/3291312-petmed-express-continues-slide-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3291312-petmed-express-continues-slide-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291307\" data-ts=\"1503507659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291307-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MN' title='Manning & Napier'>MN</a> <font color='green'>+9%</font>.</li>     <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RTNB' title='root9B Technologies, Inc.'>OTC:RTNB</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/MLP' title='Maui Land & Pineapple Company, Inc.'>MLP</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291307\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MN $RTNB $PN - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3291307-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3291307-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291305\" data-ts=\"1503507589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSX\" target=\"_blank\">CSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291305-coal-companies-call-for-formal-u-s-proceeding-against-csx\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coal companies call for formal U.S. proceeding against CSX</a></h4><ul>     <li>Coal producers Murray Energy and Foresight Energy <a href=\"https://www.platts.com/latest-news/coal/houston/murray-foresight-call-for-formal-us-stb-proceeding-21715748\" target=\"_blank\">call for a formal proceeding</a> against CSX&nbsp;(<a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a> <font color='red'>-2.1%</font>) at the U.S. Surface Transportation Board to address the railroad's \"brazen refusal to meet the demands for coal transportation.\"</li><li>Murray and Foresight say CSX harbors an \"open disregard for the coal industry\" and allege the railroad has \"cavalierly announced its intention to neglect the entire [coal] segment.\"</li><li>Murray has been particularly vocal against CSX delays (<a href=\"https://seekingalpha.com/news/3282729-regulator-warns-csx-fix-serious-issues-causing-delays-congestion\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/news/3284148-csx-apology-service-disruptions-includes-blame-employee-pushback\" target=\"_blank\">II</a>) as the railroad continues its transition  to a precision railroading model under new CEO Hunter Harrison.</li><li><em>WSJ</em> yesterday ran a report <a href=\"https://www.wsj.com/articles/waiting-for-a-train-epic-csx-traffic-jam-sows-chaos-from-coal-to-french-fries-1503417959\" target=\"_blank\">critical of CSX's changes</a> that have caused \"a summer of woe in supply chains at farms, mines [and] manufacturers.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291305\" data-linked=\"Coal companies call for formal U.S. proceeding against CSX\" data-tweet=\"$CSX - Coal companies call for formal U.S. proceeding against CSX https://seekingalpha.com/news/3291305-coal-companies-call-for-formal-u-s-proceeding-against-csx?source=tweet\" data-url=\"https://seekingalpha.com/news/3291305-coal-companies-call-for-formal-u-s-proceeding-against-csx\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291303\" data-ts=\"1503506848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291303-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/RGS' title='Regis Corporation'>RGS</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LOV' title='Spark Networks, Inc'>LOV</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MRAM' title='Everspin Technologies'>MRAM</a> <font color='green'>+12%</font>.</li>          <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RTNB' title='root9B Technologies, Inc.'>OTC:RTNB</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/BNSO' title='Bonso Electronics International, Inc.'>BNSO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CNTF' title='China TechFaith Wireless Communication Technology Limited'>CNTF</a> <font color='red'>-12%</font>. WPPGY <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/APOG' title='Apogee Enterprises, Inc.'>APOG</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BORN' title='China New Borun Corporation'>BORN</a> <font color='red'>-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291303\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CGG-OLD $PRTK $ITCI - Midday Gainers / Losers https://seekingalpha.com/news/3291303-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3291303-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291301\" data-ts=\"1503506847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291301-bottom-teva-continues-slide-down-2_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Where&#39;s the bottom? Teva continues slide, down 2.5%</a></h4><ul><li>The market's down day notwithstanding, Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color='red'>-2.5%</font>) can't seem to find a bullish friend. Shares have lost almost half their value this month.</li><li>The company is progressing on its plan to divest assets in order to pay down its substantial debt load of ~$35B. Its women's health business is on the block as is Iceland-based Medis and some of its European assets in oncology and pain management.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291026-companies-eyeing-tevas-womens-health-assets-bloomberg\" target=\"_blank\">Companies eyeing Teva's women's health assets - Bloomberg</a> (Aug. 22)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3289607-indian-drug-makers-mix-tevas-european-assets-teva-5-percent\" target=\"_blank\">Indian drug makers in the mix for Teva's European assets; Teva up 5%</a> (Aug. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291301\" data-linked=\"Where&#39;s the bottom? Teva continues slide, down 2.5%\" data-tweet=\"$TEVA - Where&#39;s the bottom? Teva continues slide, down 2.5% https://seekingalpha.com/news/3291301-bottom-teva-continues-slide-down-2_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3291301-bottom-teva-continues-slide-down-2_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>149&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291302\" data-ts=\"1503506815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESNT\" target=\"_blank\">ESNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291302-essent-group-up-4-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Essent Group up more than 4% after upgrade</a></h4><ul><li>KBW's Bose George sees Essent's (<a href='https://seekingalpha.com/symbol/ESNT' title='Essent Group Ltd.'>ESNT</a> <font color='green'>+4.2%</font>) new insurance written market share as having risen to 16.1% from 12.3% a year ago. Insurance-in-force market share should be on the rise as well.</li><li>The company may also be able to boost EPS by about 10% by ceding 50% of premiums to Essent Re, thus cutting its effective tax rate.</li><li>George upgrades to Outperform.</li><li>With today's gain, the stock is now&nbsp;<font color='green'>higher by more than 50%</font>&nbsp;Y/Y, and has mostly erased the decline associated with <a href=\"https://seekingalpha.com/pr/16909382-b-essent-b-group-ltd-prices-public-offering-common-stock\" target=\"_blank\">a capital raise</a> earlier this month.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3291302\" data-linked=\"Essent Group up more than 4% after upgrade\" data-tweet=\"$ESNT - Essent Group up more than 4% after upgrade https://seekingalpha.com/news/3291302-essent-group-up-4-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3291302-essent-group-up-4-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291297\" data-ts=\"1503504443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRPO\" target=\"_blank\">PRPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291297-precipio-readies-6m-equity-offering-shares-down-47\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Precipio readies $6M equity offering, shares down 47%</a></h4><ul><li>Thinly traded nano cap Precipio (<a href='https://seekingalpha.com/symbol/PRPO' title='Precipio, Inc.'>PRPO</a> <font color='red'>-47.1%</font>) slumps on a 26x surge in volume, albeit on turnover of only 340K shares, in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1043961/000119312517265098/d411884d8k.htm\" target=\"_blank\">planned public offering</a> of 6,000 Units at $1,000 per Unit.</li><li>Each Unit consists of one share of Series B Preferred Stock and one five-year warrant to purchase up to 400 common shares at $3.00 per share. Each Series B share is convertible into 400 shares of common at $2.50.</li><li>Net proceeds will be used for general corporate purposes.</li><li>Yesterday's close was $4.47.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291297\" data-linked=\"Precipio readies $6M equity offering, shares down 47%\" data-tweet=\"$PRPO - Precipio readies $6M equity offering, shares down 47% https://seekingalpha.com/news/3291297-precipio-readies-6m-equity-offering-shares-down-47?source=tweet\" data-url=\"https://seekingalpha.com/news/3291297-precipio-readies-6m-equity-offering-shares-down-47\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291296\" data-ts=\"1503504089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291296-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/BORN' title='China New Borun Corporation'>BORN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/COTY' title='Coty Inc.'>COTY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291296\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FTFT $ROX $NAKD - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3291296-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3291296-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291294\" data-ts=\"1503503472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRMT\" target=\"_blank\">CRMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291294-stephens-picks-up-coverage-on-americas-car-mart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens picks up coverage on America&#39;s Car-Mart</a></h4><ul> <li>Stephens launches coverage on America's Car-Mart (NASDAQ:<a href='https://seekingalpha.com/symbol/CRMT' title='America&#39;s Car-Mart, Inc.'>CRMT</a>) with an Equal-weight rating and price target of $42.</li> <li>The auto retailer isn't widely covered on Wall Street. After today's move by Stephens, there are 5 Hold equivalent ratings and one Buy rating on the books.</li> <li>Source: Bloomberg</li> <li>Shares of America's Car-Mart are down 13% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291294\" data-linked=\"Stephens picks up coverage on America&#39;s Car-Mart\" data-tweet=\"$CRMT - Stephens picks up coverage on America&#39;s Car-Mart https://seekingalpha.com/news/3291294-stephens-picks-up-coverage-on-americas-car-mart?source=tweet\" data-url=\"https://seekingalpha.com/news/3291294-stephens-picks-up-coverage-on-americas-car-mart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291293\" data-ts=\"1503503403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UTX\" target=\"_blank\">UTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291293-united-technologies-pops-on-ny-post-report-of-activist-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Technologies pops on NY Post report of activist purchase</a></h4><ul>     <li>United Technologies (<a href='https://seekingalpha.com/symbol/UTX' title='United Technologies Corporation'>UTX</a> <font color='green'>+2.2%</font>) jumps following a <em>NY Post</em> report suggesting an unidentified hedge fund - possibly Dan Loeb's Third Point - has been buying shares in the company in an attempt to <a href=\"http://nypost.com/2017/08/23/activist-shareholder-prods-united-technologies/\" target=\"_blank\">pressure it to spin off non-core businesses</a>.</li>     <li>The report speculates the moves could at least partially explain why UTX is trying to buy rival contractor  Rockwell Collins.</li>     <li>Some analysts and activists have argued that UTX would be worth at least 10% more if broken into pieces, with some suggesting the Otis Elevator unit is particularly ripe for a spinoff.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291293\" data-linked=\"United Technologies pops on NY Post report of activist purchase\" data-tweet=\"$UTX - United Technologies pops on NY Post report of activist purchase https://seekingalpha.com/news/3291293-united-technologies-pops-on-ny-post-report-of-activist-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3291293-united-technologies-pops-on-ny-post-report-of-activist-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291286\" data-ts=\"1503501100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291286-barnes-noble-vs-amazon-books-ramps-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble vs. Amazon Books ramps up</a></h4><ul> <li>Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='green'>+1.7%</font>) will start to feel Amazon's (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-1%</font>)&nbsp;presence even more with the 9th and 10th Amazon Books stores set to <a href=\"http://www.seattletimes.com/business/amazon/amazons-new-bellevue-bookstore-shows-brick-and-mortar-ramp-up/\" target=\"_blank\">open</a> this week in Bellevue, Washington and San Jose, California (<a href=\"https://www.bizjournals.com/sanjose/news/2017/08/23/amazon-unveils-its-first-bay-area-book-store.html\" target=\"_blank\">sneak preview</a>).</li> <li>Amazon Books outlets are due to open in Los Angeles, New York City and Walnut Creek, California later this year.</li> <li>\"We&rsquo;d like to be able to have as many stores as would make sense,\" says Amazon Books VP Jennifer Cast.</li><li>Analysts think Barnes &amp; Noble will have to ramp up promotions in markets in which it competes directly against Amazon for foot traffic.</li><li>Though shares of Barnes &amp; Noble are down 32% YTD to trade at a market cap of $550M, Sandell Asset Management is a believer that the company is worth $1B.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291286\" data-linked=\"Barnes &amp; Noble vs. Amazon Books ramps up\" data-tweet=\"$BKS $BKS $AMZN - Barnes &amp; Noble vs. Amazon Books ramps up https://seekingalpha.com/news/3291286-barnes-noble-vs-amazon-books-ramps-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3291286-barnes-noble-vs-amazon-books-ramps-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291260\" data-ts=\"1503500448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291260-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291260\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$PRTK $ITCI $SCYX - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3291260-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3291260-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291277\" data-ts=\"1503499483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RY\" target=\"_blank\">RY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291277-rbc-leads-canadian-lenders-higher-after-fq3-results-dividend-hike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC leads Canadian lenders higher after FQ3 results, dividend hike</a></h4><ul><li>Excluding items, FQ3 net income of C$2.796B was up 5% Y/Y; EPS of C$1.85 gained 8%. Tier 1 capital ratio is 10.9%. The quarterly dividend is hiked 5% to C$0.91 per share.</li><li>Canadian Banking net income of $1.349B gained 5% Y/Y, with volume growth of 7% offset by lower spreads.</li><li>Wealth Management net income of $486M up 25% Y/Y.</li><li>Insurance net income of $161M up 25% Y/Y (when excl. last year's sale of home and auto insurance manufacturing business).</li><li>Capital Markets is a weak spot, with net income of $611M down 4% Y/Y thanks to lower fixed-income trading results.</li><li><a href='https://seekingalpha.com/symbol/RY' title='Royal Bank of Canada'>RY</a>&nbsp;<font color='green'>+1.55%</font></li><li>Bank of Montreal (<a href='https://seekingalpha.com/symbol/BMO' title='Bank of Montreal'>BMO</a> <font color='green'>+1.2%</font>), CIBC (<a href='https://seekingalpha.com/symbol/CM' title='Canadian Imperial Bank of Commerce'>CM</a> <font color='green'>+1.4%</font>), TD Bank (<a href='https://seekingalpha.com/symbol/TD' title='Toronto-Dominion Bank'>TD</a> <font color='green'>+0.8%</font>), Scotiabank (<a href='https://seekingalpha.com/symbol/BNS' title='The Bank of Nova Scotia'>BNS</a> <font color='green'>+0.8%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291166-royal-bank-canada-misses-0_02\" target=\"_blank\">Royal Bank of Canada misses by $0.02</a> (Aug. 23)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291277\" data-linked=\"RBC leads Canadian lenders higher after FQ3 results, dividend hike\" data-tweet=\"$RY $RY $BMO - RBC leads Canadian lenders higher after FQ3 results, dividend hike https://seekingalpha.com/news/3291277-rbc-leads-canadian-lenders-higher-after-fq3-results-dividend-hike?source=tweet\" data-url=\"https://seekingalpha.com/news/3291277-rbc-leads-canadian-lenders-higher-after-fq3-results-dividend-hike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291275\" data-ts=\"1503499387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291275-snapplus-2_6-cantor-sees-share-gains-ms-cuts-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap +2.6% as Cantor sees share gains, MS cuts target</a></h4><ul>   <li>After a market-open tug-of-war, Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) is <font color='green'>up 2.6%</font> alongside a bullish update from Cantor Fitzgerald and a price target cut from Morgan Stanley.</li>    <li>Cantor reiterated its Overweight rating and $15 price target, noting that it sees the social-media \"camera company\" gaining share among younger consumers and predicting more engagement with the rapid rise of its shows.</li>    <li>Video could mean another incremental tailwind for ARPU in the coming 12 months, says analyst Kip Paulson. (h/t/ Bloomberg)</li>    <li>Morgan Stanley, meanwhile, has cut its price target to $14 from $16 (now implying 6% downside) and trimmed its ad revenue estimates by 8% for 2018 and by 9% for 2019.</li>    <li>The ad business is taking longer to scale, says analyst Brian Nowak (who has an Equal-Weight rating); the core ad product still lacks performance, measurability and ROI.</li>    <li>We're six days from the company's next IPO lockup expiration.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291275\" data-linked=\"Snap +2.6% as Cantor sees share gains, MS cuts target\" data-tweet=\"$SNAP - Snap +2.6% as Cantor sees share gains, MS cuts target https://seekingalpha.com/news/3291275-snapplus-2_6-cantor-sees-share-gains-ms-cuts-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3291275-snapplus-2_6-cantor-sees-share-gains-ms-cuts-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291274\" data-ts=\"1503498973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291274-417m-california-verdict-in-j-and-j-baby-powder-case-suggests-forum-shopping-legal-experts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">$417M California verdict in J&amp;J baby powder case suggests forum-shopping - legal experts; shares down 1%</a></h4><ul><li><a href=\"http://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit-analys-idUSKCN1B22HQ\" target=\"_blank\">Legal experts say</a> the recent $417M awarded to a woman in a California district court against Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color='red'>-1%</font>) suggests forum-shopping, meaning plaintiffs seek to file cases in favorable jurisdictions.</li><li>The award, the largest to date by far, opens a new front in the litigation. The company hoped to confine the baby powder lawsuits to Missouri, where a St. Louis district court was hearing a number of the cases. A total of $307M has been awarded there to date.</li><li>Companies have long fought the practice, a stance backed by a June ruling by the U.S. Supreme Court stating that state courts should not hear claims against out-of-state firms when the alleged injury did not occur there. A St. Louis judge subsequently declared a mistrial in a talc case involving two out-of-state women.</li><li>J&amp;J maintains that the Supreme Court ruling requires the reversal of the four unfavorable St. Louis verdicts.</li><li>The Los Angeles judge allowed the testimony of some of the St. Louis plaintiffs' experts.</li><li>The company faces ~4,800 lawsuits claiming the use of its baby powder led to ovarian cancer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290788-j-and-j-hook-417m-california-talcum-powder-case\" target=\"_blank\">J &amp; J on the hook for $417M in California talcum powder case</a> (Aug. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291274\" data-linked=\"$417M California verdict in J&amp;J baby powder case suggests forum-shopping - legal experts; shares down 1%\" data-tweet=\"$JNJ - $417M California verdict in J&amp;J baby powder case suggests forum-shopping - legal experts; shares down 1% https://seekingalpha.com/news/3291274-417m-california-verdict-in-j-and-j-baby-powder-case-suggests-forum-shopping-legal-experts?source=tweet\" data-url=\"https://seekingalpha.com/news/3291274-417m-california-verdict-in-j-and-j-baby-powder-case-suggests-forum-shopping-legal-experts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291273\" data-ts=\"1503498677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291273-crude-futures-flat-post-inventory-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude futures flat post inventory data</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>-3.3M</strong> barrels vs. -3.5M consensus, -8.9M last week.</li><li>Gasoline <strong>-1.2</strong><strong>M</strong> barrels&nbsp;vs. -0.6M consensus, 0.0M last week.</li><li>Distillates <b>Unchanged</b>&nbsp;vs. +0.1M consensus, +0.7M last week.</li><li>Futures&nbsp;<font color='green'>+0.02%</font>&nbsp;to $47.84.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3291273\" data-linked=\"Crude futures flat post inventory data\" data-tweet=\"$USO $OIL $UCO - Crude futures flat post inventory data https://seekingalpha.com/news/3291273-crude-futures-flat-post-inventory-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3291273-crude-futures-flat-post-inventory-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291272\" data-ts=\"1503498638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLCO\" target=\"_blank\">MLCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291272-macau-sector-lower-after-major-typhoon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau sector lower after major typhoon</a></h4><ul> <li>Casinos in Macau are closed or are running at diminished capacity after Typhoon Hato blasted the region. Anecdotal reports indicate that casino gaming floors are nearly empty as might be expected after the strongest storm in five years pounded the region.</li> <li>Earlier estimates on the negative impact on August gaming revenue range from Hato range as high as a couple of hundred basis points (JPMorgan) to 80-90 bps (Nomura). The hit to revenue is minor compared to the +25% to +29% forecasts for the full month and the low double-digit growth seen for the quarter as tougher comparable start to pile in.</li> <li>Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) is <font color='red'>down 2.77%</font> in a move that is the most notable dip in the sector.</li>    <li>Macau casino stocks: Wynn Macau (<a href='https://seekingalpha.com/symbol/WYNMF' title='Wynn Macau Ltd.'>OTCPK:WYNMF</a>, <a href='https://seekingalpha.com/symbol/WYNMY' title='Wynn Macau Ltd. ADR'>OTCPK:WYNMY</a>, <a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>), Sands China (<a href='https://seekingalpha.com/symbol/SCHYY' title='Sands China Ltd ADR'>OTCPK:SCHYY</a>, <a href='https://seekingalpha.com/symbol/SCHYF' title='Sands China Ltd'>OTCPK:SCHYF</a>, <a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>), MGM China (<a href='https://seekingalpha.com/symbol/MCHVF' title='MGM China Holdings, Ltd.'>OTCPK:MCHVF</a>, <a href='https://seekingalpha.com/symbol/MCHVY' title='MGM China Holdings, Ltd. ADR'>OTCPK:MCHVY</a>, <a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>), Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>), SJM Holdings (<a href='https://seekingalpha.com/symbol/SJMHF' title='SJM Holdings Ltd.'>OTCPK:SJMHF</a>, <a href='https://seekingalpha.com/symbol/SJMHY' title='SJM Holdings Ltd. ADR'>OTCPK:SJMHY</a>).</li>     <li>Related ETF: <a href='https://seekingalpha.com/symbol/BJK' title='VanEck Vectors Gaming ETF'>BJK</a>.</li><li>Sources: GGR and Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291182-typhoon-hato-hits-macau\" target=\"_blank\">Typhoon Hato hits Macau</a> (Aug. 23)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291272\" data-linked=\"Macau sector lower after major typhoon\" data-tweet=\"$MLCO $MLCO $WYNMF - Macau sector lower after major typhoon https://seekingalpha.com/news/3291272-macau-sector-lower-after-major-typhoon?source=tweet\" data-url=\"https://seekingalpha.com/news/3291272-macau-sector-lower-after-major-typhoon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291271\" data-ts=\"1503497891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291271-whole-foods-shareholders-approve-amazon-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whole Foods shareholders approve Amazon deal</a></h4><ul> <li>Shareholders at Whole Foods Market (WFM) approved the company's acquisition by Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-1%</font>).</li> <li>Shares of Whole Foods trade at $41.74 vs. the $42 deal price.</li> <li>Source: CNBC</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3291271\" data-linked=\"Whole Foods shareholders approve Amazon deal\" data-tweet=\"$AMZN - Whole Foods shareholders approve Amazon deal https://seekingalpha.com/news/3291271-whole-foods-shareholders-approve-amazon-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3291271-whole-foods-shareholders-approve-amazon-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291267\" data-ts=\"1503497744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTK\" target=\"_blank\">FTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291267-flotek-says-sec-closes-inquiry-no-enforcement-action-taken\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flotek says SEC closes inquiry with no enforcement action taken</a></h4><ul>     <li>Flotek Industries (<a href='https://seekingalpha.com/symbol/FTK' title='Flotek Industries, Inc.'>FTK</a> <font color='green'>+2.9%</font>) is higher after saying the SEC has <a href=\"https://seekingalpha.com/pr/16921615-flotek-industries-inc-announces-conclusion-sec-inquiry\" target=\"_blank\">closed its inquiry</a> into the company's FracMax software and the efficacy of CnF, and will not recommend any enforcement action.</li>     <li>FTK says the findings of its own outside review process, which have been previously disclosed, were consistent with the SEC recommendation to take no action against the company.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291267\" data-linked=\"Flotek says SEC closes inquiry with no enforcement action taken\" data-tweet=\"$FTK - Flotek says SEC closes inquiry with no enforcement action taken https://seekingalpha.com/news/3291267-flotek-says-sec-closes-inquiry-no-enforcement-action-taken?source=tweet\" data-url=\"https://seekingalpha.com/news/3291267-flotek-says-sec-closes-inquiry-no-enforcement-action-taken\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291266\" data-ts=\"1503497368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291266-starbucks-slips-after-cleveland-research-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starbucks slips after Cleveland Research downgrade</a></h4><ul> <li>Cleveland Research lowers Starbucks (NASDAQ:<a href='https://seekingalpha.com/symbol/SBUX' title='Starbucks Corporation'>SBUX</a>) to a Neutral rating after having the retail stock set at Buy.</li> <li>The downgrade from the boutique firm follows closely on a Barron's pitch that Starbucks has 20% upside for investors.</li> <li>Shares of Starbucks are <font color='red'>down 1.27%</font> to $53.75 vs. a 52-week trading range of $50.84 to $64.87.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290636-tech-platform-seen-driving-gains-starbucks\" target=\"_blank\">Tech platform seen driving gains for Starbucks</a> (Aug. 21)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291002-morgan-stanley-crunches-numbers-starbucks\" target=\"_blank\">Morgan Stanley crunches the numbers on Starbucks</a> (Aug. 22)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291266\" data-linked=\"Starbucks slips after Cleveland Research downgrade\" data-tweet=\"$SBUX - Starbucks slips after Cleveland Research downgrade https://seekingalpha.com/news/3291266-starbucks-slips-after-cleveland-research-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3291266-starbucks-slips-after-cleveland-research-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291259\" data-ts=\"1503496500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PURE\" target=\"_blank\">PURE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291259-pure-bios-control-antimicrobial-included-in-approved-list-of-safe-ingredients-for-meat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pure Bio&#39;s Control antimicrobial included in approved list of safe ingredients for meat, poultry and egg product production</a></h4><ul><li>PURE Bioscience (<a href='https://seekingalpha.com/symbol/PURE' title='PURE Bioscience'>OTC:PURE</a> <font color='red'>-2.5%</font>) <a href=\"https://seekingalpha.com/pr/16922010-pure-control-antimicrobial-listed-safe-suitable-ingredient-usda-fsis-directive-7120_1-poultry\" target=\"_blank\">announces </a>that its PURE Control antimicrobial is included in the updated list of Safe and Suitable Ingredients Used in Production of Meat, Poultry and Egg Products in the Food Safety and Inspection Service <a href=\"https://www.fsis.usda.gov/wps/wcm/connect/bab10e09-aefa-483b-8be8-809a1f051d4c/7120.1.pdf?MOD=AJPERES\" target=\"_blank\">7120.1 Directive</a>.</li><li>The company says it has launched commercialization of PURE Control to poultry processors.</li><li>PURE Control is designed to reduce Salmonella, Campylobactor and other pathogens to prevent foodborne illness.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291259\" data-linked=\"Pure Bio&#39;s Control antimicrobial included in approved list of safe ingredients for meat, poultry and egg product production\" data-tweet=\"$PURE - Pure Bio&#39;s Control antimicrobial included in approved list of safe ingredients for meat, poultry and egg product production https://seekingalpha.com/news/3291259-pure-bios-control-antimicrobial-included-in-approved-list-of-safe-ingredients-for-meat?source=tweet\" data-url=\"https://seekingalpha.com/news/3291259-pure-bios-control-antimicrobial-included-in-approved-list-of-safe-ingredients-for-meat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291257\" data-ts=\"1503496059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291257-reuters-infosys-investors-want-former-ceo-back-to-end-fighting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Infosys investors want former CEO back to end fighting</a></h4><ul><li>        A dozen major investors want Infosys (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>) to appoint former CEO Nandan Nilekani to the board to resolve an ongoing feud between the board and the company&rsquo;s founders, according to <a href=\"http://www.reuters.com/article/us-infosys-investors-idUSKCN1B31IF?il=0\" target=\"_blank\">Reuters</a>.</li><li>               CEO Vishal Sikka resigned on Friday after several months of in-fighting that had the founders questioning the governance of the directors.&nbsp;</li><li>               Nilekani, another co-founder, was CEO from 2002 to 2007.&nbsp;</li><li>               Investor letter comments about Nilekani: \"Given his credentials, we feel, that his joining the board at this stage, will restore confidence of stakeholders in the company and also facilitate resolution of the contentious issues that Infosys is facing presently.&rdquo;&nbsp;</li><li>               Infosys shares are&nbsp;<font color='green'>up 2.03%</font>, erasing some of the past week&rsquo;s losses but still down nearly 8%.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290559-infosys-offers-buyback-ceo-quits\" target=\"_blank\">Infosys offers buyback after CEO quits</a> (Aug. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291257\" data-linked=\"Reuters: Infosys investors want former CEO back to end fighting\" data-tweet=\"$INFY - Reuters: Infosys investors want former CEO back to end fighting https://seekingalpha.com/news/3291257-reuters-infosys-investors-want-former-ceo-back-to-end-fighting?source=tweet\" data-url=\"https://seekingalpha.com/news/3291257-reuters-infosys-investors-want-former-ceo-back-to-end-fighting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291245\" data-ts=\"1503494779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCIX\" target=\"_blank\">DCIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291245-diana-containerships-falls-after-unveiling-reverse-stock-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diana Containerships falls after unveiling reverse stock split</a></h4><ul>         <li>Diana Containerships (NASDAQ:<a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a>)&nbsp;announces a reverse one-for-seven stock split of shares.</li>     <li>The reverse stock split will take effect on or around August 24.</li>     <li>DCIX  <font color='red'>-20.76%</font> premarket to  $0.35.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/16922146-diana-containerships-inc-announces-one-seven-reverse-stock-split\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3291245\" data-linked=\"Diana Containerships falls after unveiling reverse stock split\" data-tweet=\"$DCIX - Diana Containerships falls after unveiling reverse stock split https://seekingalpha.com/news/3291245-diana-containerships-falls-after-unveiling-reverse-stock-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3291245-diana-containerships-falls-after-unveiling-reverse-stock-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291243\" data-ts=\"1503494632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LZB\" target=\"_blank\">LZB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291243-la-z-boy-plunges-after-margins-shrink\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La-Z-Boy plunges after margins shrink</a></h4><ul> <li>Shares of La-Z-Boy (NYSE:<a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a>) fall sharply after a painful drop in operating margin in <a href=\"https://seekingalpha.com/news/3291090-la-z-boy-misses-0_08-misses-revenue\" target=\"_blank\">Q2</a> to 8.5% from 11.4% a year ago.</li> <li>The company saw a reduced level of sales leverage due to lower volume.</li><li>Stifel Nicolaus warns that the costs of adding new stores coudl continue to drag on margins.</li> <li>The <font color='red'>18% drop</font> in LZB in premarket trading erases a bulk of the gains built up since the middle part of June.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291243\" data-linked=\"La-Z-Boy plunges after margins shrink\" data-tweet=\"$LZB - La-Z-Boy plunges after margins shrink https://seekingalpha.com/news/3291243-la-z-boy-plunges-after-margins-shrink?source=tweet\" data-url=\"https://seekingalpha.com/news/3291243-la-z-boy-plunges-after-margins-shrink\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291240\" data-ts=\"1503494283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291240-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color='green'>+29%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3291224-intra-cellular-gets-good-news-fda-related-toxicity-lumateperone-shares-ahead-33-percent\" target=\"_blank\">FDA news</a> related to toxicity of lumateperone</li><li><a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a> <font color='green'>+24%</font>&nbsp;on rumored <a href=\"https://seekingalpha.com/news/3291213-paratek-pharmaceuticals-mulling-sale-shares-ahead-28-percent-premarket\" target=\"_blank\">takeover interest</a>.</li><li><a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='green'>+17%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3291176-express-beats-0_02-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+11%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3291204-american-eagle-outfitters-beats-0_03-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a> <font color='green'>+7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291240\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$ITCI $PRTK $EXPR - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3291240-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3291240-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291236\" data-ts=\"1503493987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVM\" target=\"_blank\">CVM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291236-cel-sci-announces-private-3_5m-capital-raise-2-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CEL-SCI announces private $3.5M capital raise at $2/share</a></h4><ul><li>CEL-SCI (NYSEMKT:<a href='https://seekingalpha.com/symbol/CVM' title='Cel-Sci Corporation'>CVM</a>) is poised for an opening gap down in response to its <a href=\"https://seekingalpha.com/pr/16922101-cel-sci-announces-3_5-million-registered-direct-offering\" target=\"_blank\">announcement </a>of a private placement of 1.75M shares of common stock at $2 per share. Each share sold will have an accompanying five-year warrant to purchase one share of common at $2.30.</li><li>Net proceeds will fund a Phase 3 clinical trial and general corporate purposes.</li><li>Yesterday's close was $2.29.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>10%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291236\" data-linked=\"CEL-SCI announces private $3.5M capital raise at $2/share\" data-tweet=\"$CVM - CEL-SCI announces private $3.5M capital raise at $2/share https://seekingalpha.com/news/3291236-cel-sci-announces-private-3_5m-capital-raise-2-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3291236-cel-sci-announces-private-3_5m-capital-raise-2-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291235\" data-ts=\"1503493951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291235-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/RTNB' title='root9B Technologies, Inc.'>OTC:RTNB</a> <font color='red'>-37%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16921602-root9b-holdings-inc-announces-incremental-funding-status-foreclosure\" target=\"_blank\">announcing</a> incremental funding and status of foreclosure.</li><li><a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3291090-la-z-boy-misses-0_08-misses-revenue\" target=\"_blank\">Q1 earnings</a> miss.</li><li><a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a>&nbsp;<font color='red'>-13%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3291091-ultragenyxs-ace-er-flunks-late-stage-study-gne-myopathy-shares-10-percent-hours\" target=\"_blank\">announcing</a> top-line results from Phase 3 study of Ace-ER in GNE Myopathy.</li><li><a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3291079-cree-eps-line-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3291235\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$RTNB $LZB $RARE - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3291235-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3291235-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291234\" data-ts=\"1503493607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYK\" target=\"_blank\">SYK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291234-stryker-softens-guidance-recalls-lot-of-oral-care-products-shares-slip-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stryker softens guidance, recalls lot of Oral Care products; shares slip 2% premarket</a></h4><ul><li>Stryker (NYSE:<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a>) is down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume after it <a href=\"http://www.marketwatch.com/story/stryker-corp-stock-drops-2-on-voluntary-recall-temporary-ship-hold-and-lowered-2017-earnings-guidance-2017-08-23?mg=prod/accounts-mw\" target=\"_blank\">announced </a>that it expects Q3 and 2017 non-GAAP EPS to be at the low end of the previously announced ranges of $1.50 - 1.55 and $6.45 - 6.55, respectively.</li><li>It has issued a voluntary recall of specific lots of Oral Care products sold through its Sage Products unit and placed a temporary hold on cloth-based products after receiving reports of minor irritation and allergic reactions. The company says it has stopped doing business with the third-party supplier and is now making the Oral Car products in-house. Shipments should restart in September.</li><li>The FDA warned the company in July about the issues.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291234\" data-linked=\"Stryker softens guidance, recalls lot of Oral Care products; shares slip 2% premarket\" data-tweet=\"$SYK - Stryker softens guidance, recalls lot of Oral Care products; shares slip 2% premarket https://seekingalpha.com/news/3291234-stryker-softens-guidance-recalls-lot-of-oral-care-products-shares-slip-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3291234-stryker-softens-guidance-recalls-lot-of-oral-care-products-shares-slip-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291224\" data-ts=\"1503492729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITCI\" target=\"_blank\">ITCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291224-intra-cellular-gets-good-news-from-fda-related-to-toxicity-of-lumateperone-shares-ahead-33\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intra-Cellular gets good news from FDA related to toxicity of lumateperone; shares ahead 33% premarket</a></h4><ul><li>Thinly traded micro cap Intra-Cellular Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a>) jumps&nbsp;<font color='green'>33%&nbsp;</font>premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16921898-intra-cellular-therapies-announces-positive-regulatory-update-schizophrenia-program\" target=\"_blank\">announcement </a>that the FDA has agreed that the toxicity from schizophrenia candidate lumateperone observed in nonclinical studies in animal models is not relevant to humans considering their distinctive metabolic pathways.</li><li>In May, shares tanked on the news that the agency asked for more information related to the studies.</li><li>The company says it plans to file its NDA by mid-2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261652-intra-cellular-therapies-sinks-fda-info-request\" target=\"_blank\">Intra-Cellular Therapies sinks after FDA info request</a> (May 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291224\" data-linked=\"Intra-Cellular gets good news from FDA related to toxicity of lumateperone; shares ahead 33% premarket\" data-tweet=\"$ITCI - Intra-Cellular gets good news from FDA related to toxicity of lumateperone; shares ahead 33% premarket https://seekingalpha.com/news/3291224-intra-cellular-gets-good-news-from-fda-related-to-toxicity-of-lumateperone-shares-ahead-33?source=tweet\" data-url=\"https://seekingalpha.com/news/3291224-intra-cellular-gets-good-news-from-fda-related-to-toxicity-of-lumateperone-shares-ahead-33\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291225\" data-ts=\"1503492434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUTR\" target=\"_blank\">NUTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291225-trading-in-nutraceutical-halted\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading in Nutraceutical halted</a></h4><ul><li>Nasdaq has suspended trading in Nutraceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/NUTR' title='Nutraceutical International Corporation'>NUTR</a>) pending news. Two days ago, shareholders backed private equity firm HGGC's $41.80/share bid.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291225\" data-linked=\"Trading in Nutraceutical halted\" data-tweet=\"$NUTR - Trading in Nutraceutical halted https://seekingalpha.com/news/3291225-trading-in-nutraceutical-halted?source=tweet\" data-url=\"https://seekingalpha.com/news/3291225-trading-in-nutraceutical-halted\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291213\" data-ts=\"1503490663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTK\" target=\"_blank\">PRTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291213-paratek-pharmaceuticals-mulling-sale-shares-ahead-28-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paratek Pharmaceuticals mulling sale; shares ahead 28% premarket</a></h4><ul><li>Paratek Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PRTK' title='Paratek Pharmaceuticals, Inc.'>PRTK</a>) is up&nbsp;<font color='green'>28%</font>&nbsp;premarket on increased volume on rumored takeover interest. In May, Allergan, the U.S. licensor of Paratek's sarecycline, was reportedly the interested party.</li><li>The company's lead candidate is antibiotic omadacycline, successful in three late-stage studies.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3279038-parateks-omadacycline-successful-late-stage-study-absssi-shares-ahead-7-percent-hours\" target=\"_blank\">Paratek's omadacycline successful in late-stage study in ABSSSI; shares ahead 7% after hours</a> (July 17)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3263684-ft-paratek-pharma-play-shares-jump-nearly-7-percent\" target=\"_blank\">FT: Paratek Pharma in play? Shares jump nearly 7%</a> (May 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3291213\" data-linked=\"Paratek Pharmaceuticals mulling sale; shares ahead 28% premarket\" data-tweet=\"$PRTK - Paratek Pharmaceuticals mulling sale; shares ahead 28% premarket https://seekingalpha.com/news/3291213-paratek-pharmaceuticals-mulling-sale-shares-ahead-28-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3291213-paratek-pharmaceuticals-mulling-sale-shares-ahead-28-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291209\" data-ts=\"1503490469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291209-american-eagle-outfitters-higher-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Eagle Outfitters higher on earnings beat</a></h4><ul>     <li>American Eagle Outfitters (NYSE:<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a>) reports comparable sales rose 2% in <a href=\"https://seekingalpha.com/pr/16921912-american-eagle-outfitters-report-second-quarter-results-comp-sales-increased-2-percent-sales\" target=\"_blank\">Q2</a>.</li>     <li>Gross margin rate down 240 bps to 36.5%, due to increased promotional activity and higher shipping costs and rent.</li>     <li>SG&amp;A expense rate leveraged 20 bps to 24.1%.</li>     <li>Adjusted operating margin rate squeezed 230 bps to 6%.</li>     <li>Merchandise inventory&nbsp;+2.7% Y/Y to $433.46M.</li>     <li>Store count +4 Q/Q to 1,057.</li>     <li><b>Q3 Guidance</b>: Comparable-store sales:&nbsp;flat to up low single digit; Diluted EPS: ~$0.36 to $0.38.</li>     <li><b>FY2017 Guidance</b>:&nbsp;Capex: $160M to $170M; Store count: 1,042 - 1,062.</li>     <li>AEO&nbsp;<font color='green'>+12.85%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291209\" data-linked=\"American Eagle Outfitters higher on earnings beat\" data-tweet=\"$AEO - American Eagle Outfitters higher on earnings beat https://seekingalpha.com/news/3291209-american-eagle-outfitters-higher-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3291209-american-eagle-outfitters-higher-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291186\" data-ts=\"1503486941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CANF\" target=\"_blank\">CANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291186-can-fite-received-500k-milestone-from-korean-distribution-partner-chong-kun-dang\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Can-Fite received $500K milestone from Korean distribution partner Chong Kun Dang</a></h4><ul><li>Can-Fite BioPharma (NYSEMKT:<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite BioPharma Ltd.'>CANF</a>) <a href=\"https://seekingalpha.com/pr/16921768-can-fite-receives-milestone-payment-ckd-pharmaceuticals-distribution-partner-korea\" target=\"_blank\">receives </a>a $500K milestone payment from distribution partner Chong Kun Dang Pharmaceuticals &#40;CKD&#41; related to regulatory approvals for Namodenoson for liver cancer in Korea. It has received $1M to date and could earn up to an additional $2M in milestones. It also earns a 23% royalty on net sales there.</li><li>The company's Korean distributor for Picllidenson for rheumatoid arthritis is Kwang Dong Pharmaceutical.</li><li>Shares are down&nbsp;<font color='red'>3%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291186\" data-linked=\"Can-Fite received $500K milestone from Korean distribution partner Chong Kun Dang\" data-tweet=\"$CANF - Can-Fite received $500K milestone from Korean distribution partner Chong Kun Dang https://seekingalpha.com/news/3291186-can-fite-received-500k-milestone-from-korean-distribution-partner-chong-kun-dang?source=tweet\" data-url=\"https://seekingalpha.com/news/3291186-can-fite-received-500k-milestone-from-korean-distribution-partner-chong-kun-dang\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291185\" data-ts=\"1503486883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPR\" target=\"_blank\">EXPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291185-e-commerce-sales-sizzle-for-express\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E-commerce sales sizzle for Express</a></h4><ul> <li>Express (NYSE:<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a>) reports same-store sales fell 4% in Q2 to top the 5.2% drop anticipated by analysts.</li> <li>E-commerce sales rose 28% Y/Y to account for 19% of all sales.</li> <li>Merchandise margin fell 120 bps as the company's exit from Canada and promotions chipped away.</li> <li>Looking ahead, Express sees Q3 same-store sales down in a low single-digit rate and EPS of $0.06 to $0.10 vs. $0.11 consensus. Guidance for full-year EPS is $0.41 to $0.48 vs. $0.42 consensus.</li> <li>\"We expect e-commerce sales growth to remain solid and store performance to sequentially improve, driven in part by our expanded omni-channel capabilities,\" says CEO David Kornberg.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3291176-express-beats-0_02-beats-revenue\" target=\"_blank\">Express beats by $0.02, beats on revenue</a> (Aug. 23)</li> <li>EXPR <font color='green'>+11.11%</font> premarket to $6.10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3291185\" data-linked=\"E-commerce sales sizzle for Express\" data-tweet=\"$EXPR - E-commerce sales sizzle for Express https://seekingalpha.com/news/3291185-e-commerce-sales-sizzle-for-express?source=tweet\" data-url=\"https://seekingalpha.com/news/3291185-e-commerce-sales-sizzle-for-express\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291179\" data-ts=\"1503485949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGS\" target=\"_blank\">RGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291179-on-regis-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Regis&#39; Q4</a></h4><ul><li>Regis (NYSE:<a href='https://seekingalpha.com/symbol/RGS' title='Regis Corporation'>RGS</a>) reports same-store sales rose 0.4% in <a href=\"https://seekingalpha.com/pr/16921728-regis-reports-fourth-quarter-2017-full-year-results\" target=\"_blank\">Q4</a>.</li><li>Service revenue fell 5.6% to $329.51M.</li><li>Product revenue down 6% to $81.47M.</li><li>Royalties and fees increased 9.4% to $13.22M.</li><li>Segment revenues: North American Value: $320.3M (-2.6%); North American Franchise: $21.7M (+4.7%); North American Premium: $56.8M (-16.3%); International: $25.9M (-15.8%).</li><li>Adjusted EBITDA grew 11.7% to $30.7M.</li><li>Segment store count: North American Value: 5,439 (-331 Y/Y); North American Franchise: 2,633 (+137 Y/Y); North American Premium: 559 (-135 Y/Y); International: 288M (-40 Y/Y).</li></ul><div class=\"tiny-share-widget\" data-id=\"3291179\" data-linked=\"More on Regis&#39; Q4\" data-tweet=\"$RGS - More on Regis&#39; Q4 https://seekingalpha.com/news/3291179-on-regis-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3291179-on-regis-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3291167\" data-ts=\"1503484742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOW\" target=\"_blank\">LOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3291167-lowes-down-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lowe&#39;s down on earnings miss</a></h4><ul><li>Lowe's (NYSE:<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a>) reports comparable-store sales rose 4.5% in <a href=\"https://seekingalpha.com/pr/16921716-lowes-reports-second-quarter-sales-earnings-results\" target=\"_blank\">Q2</a>.</li><li>Comps for the U.S.&nbsp;home improvement&nbsp;business grew 4.6% for the quarter.</li><li>Gross margin rate fell 23 bps to 34.21%.</li><li>SG&amp;A expense rate improved 101 bps to 20.16%.</li><li>Operating margin rate advanced 98 bps to 12.22%.</li><li>Merchandise inventory +7.6% to $11.41B.</li><li>Home improvement and hardware stores +33 Y/Y to 2,141.</li><li><b>FY2017 Guidance</b>: Sales growth: ~+5%;&nbsp;Comparable-store sales: ~+3.5%; Operating margin: +80 to +100 bps; Tax rate: 36.9%; Diluted&nbsp;EPS: $4.20 to $4.30; New stores: ~35.</li><li>LOW&nbsp;<font color='red'>-5.7%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3291167\" data-linked=\"Lowe&#39;s down on earnings miss\" data-tweet=\"$LOW - Lowe&#39;s down on earnings miss https://seekingalpha.com/news/3291167-lowes-down-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3291167-lowes-down-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":59,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}